Jodid (Potassium Iodide)

Potassium iodide releases iodide ions that flood the thyroid’s sodium‑iodide symporter, saturating the gland with stable iodine. This competitive inhibition prevents the thyroid from absorbing harmful radioactive iodine isotopes, thereby reducing the radiation dose delivered to the thyroid tissue.

The appropriate dose of Jodid is determined by the prescribing clinician based on the specific indication, the patient’s age, weight, and the level of radioactive exposure risk. Dosage recommendations follow national and international guidelines and should not be altered without medical advice.

Safety data for potassium iodide in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing Jodid to pregnant or breastfeeding individuals. If used, it should be under strict medical supervision.

To order Jodid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Jodid’s active ingredient, potassium iodide, is the standard oral iodine source for thyroid blocking. Alternative preparations may contain different salts or formulations, but potassium iodide remains the most widely studied and recommended agent for rapid thyroid saturation in emergency settings.

Jodid should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme heat to maintain its stability and potency throughout its shelf life.

Jodid is taken orally, usually with a glass of water. The tablet or capsule should be swallowed whole unless the prescribing information advises otherwise. Administration timing is critical in radiation emergencies, and the dose should be taken as soon as possible after exposure risk is identified.

Serious risks include severe allergic reactions such as anaphylaxis, significant thyroid dysfunction (either hypothyroidism or hyperthyroidism), and iodide‑induced thyroiditis. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling of the face or throat, or abrupt changes in thyroid function.

Jodid is contraindicated in individuals with a known allergy to iodine or potassium iodide, untreated hyperthyroidism, or active thyroid disease that could be worsened by excess iodide. It should also be used with caution in patients with severe renal impairment or those taking interacting medications.